Published in JAMA Intern Med on May 13, 2013
Tailored Screening for Breast Cancer in Premenopausal Women (TBST) | NCT02619123
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA (2015) 6.38
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med (2014) 3.78
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol (2015) 2.02
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. J Natl Cancer Inst (2014) 1.27
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. J Natl Cancer Inst (2014) 1.04
Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med (2016) 0.94
Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast Cancer (Dove Med Press) (2015) 0.93
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med (2016) 0.92
To screen or not to screen older women for breast cancer: a conundrum. Future Oncol (2013) 0.85
Listening to Women: Expectations and Experiences in Breast Imaging. J Womens Health (Larchmt) (2015) 0.84
Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram. Cancer Epidemiol Biomarkers Prev (2015) 0.81
Mammographic quantitative image analysis and biologic image composition for breast lesion characterization and classification. Med Phys (2014) 0.80
Photoacoustic Imaging in Oncology: Translational Preclinical and Early Clinical Experience. Radiology (2016) 0.79
Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer. PLoS One (2016) 0.79
Reconsidering the age thresholds for type II diabetes screening in the U.S. Am J Prev Med (2014) 0.79
Non-invasive optical estimate of tissue composition to differentiate malignant from benign breast lesions: A pilot study. Sci Rep (2017) 0.77
Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST). Med Care (2015) 0.77
Is the false-positive rate in mammography in North America too high? Br J Radiol (2016) 0.76
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res (2016) 0.75
The impact of mammographic screening on the surgical management of breast cancer. J Surg Oncol (2016) 0.75
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Ann Intern Med (2016) 0.75
Surgical margin reporting in breast conserving surgery: Does compliance with guidelines affect re-excision and mastectomy rates? Breast (2015) 0.75
A novel method to assess incompleteness of mammography reports. AMIA Annu Symp Proc (2014) 0.75
Non-normal Screening Mammography Results, Lumpectomies, and Breast Cancer Reported by California Women, 2001-2009. Womens Health Issues (2015) 0.75
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Analysis of Participant Factors That Affect the Diagnostic Performance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea. Korean J Radiol (2017) 0.75
Quantitative contrast-enhanced spectral mammography based on photon-counting detectors: A feasibility study. Med Phys (2017) 0.75
The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer (2017) 0.75
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 21.55
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62
Efficacy of screening mammography. A meta-analysis. JAMA (1995) 6.94
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med (2009) 4.60
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst (2003) 3.83
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst (1998) 3.08
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA (2001) 2.45
Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast (2005) 2.06
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol (2010) 1.94
Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.91
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst (2011) 1.75
Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69
Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology (2004) 1.51
The mammogram that cried Wolfe. N Engl J Med (2007) 1.37
Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. AJR Am J Roentgenol (2007) 1.34
Case-control study of increased mammographic breast density response to hormone replacement therapy. Cancer Epidemiol Biomarkers Prev (2002) 1.28
Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.19
Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study. Breast J (2012) 1.18
Size, node status and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol (2000) 1.16
Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer (2005) 1.16
Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect. Breast Cancer Res (2005) 0.84
Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med (2009) 10.27
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Comparing yoga, exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. Ann Intern Med (2005) 5.11
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry (2006) 5.06
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) (2008) 4.05
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Effectiveness of computer-aided detection in community mammography practice. J Natl Cancer Inst (2011) 3.62
Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst (2010) 3.53
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. JAMA Intern Med (2015) 3.38
Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med (2004) 2.93
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst (2007) 2.87
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Physician predictors of mammographic accuracy. J Natl Cancer Inst (2005) 2.72
Screening mammograms by community radiologists: variability in false-positive rates. J Natl Cancer Inst (2002) 2.71
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA (2009) 2.59
Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain (2005) 2.50
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (2007) 2.36
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol (2008) 2.11
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol (2009) 2.10
Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med (2014) 2.08
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol (2015) 2.02
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol (2010) 1.94
Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol (2007) 1.89
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China. Am J Epidemiol (2013) 1.82
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev (2009) 1.75
Breast cancer detection rate: designing imaging trials to demonstrate improvements. Radiology (2007) 1.73
Self-detection remains a key method of breast cancer detection for U.S. women. J Womens Health (Larchmt) (2011) 1.53
Physician workload in mammography. AJR Am J Roentgenol (2008) 1.53
Comparing the performance of mammography screening in the USA and the UK. J Med Screen (2005) 1.52
A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring. Biometrics (2013) 1.52
Modeling the dissemination of mammography in the United States. Cancer Causes Control (2005) 1.52
Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort study. Int J Epidemiol (2005) 1.50
Sun protection at elementary schools: a cluster randomized trial. J Natl Cancer Inst (2010) 1.50
Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? AJR Am J Roentgenol (2010) 1.49
A trial of an activating intervention for chronic back pain in primary care and physical therapy settings. Pain (2005) 1.49
Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke (2008) 1.48
Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst (2013) 1.48
Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control (2008) 1.47
Disclosing harmful mammography errors to patients. Radiology (2009) 1.45
Association of insulin resistance with distance to wealthy areas: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2006) 1.41
Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS One (2010) 1.41
Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev (2012) 1.39
Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. Maturitas (2010) 1.38
Oral health-related quality of life in Germany. Eur J Oral Sci (2003) 1.38
Randomized trial of therapeutic massage for chronic neck pain. Clin J Pain (2009) 1.37
Distinguishing screening from diagnostic mammograms using Medicare claims data. Med Care (2014) 1.37
Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst (2008) 1.35
Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst (2013) 1.34
A prognostic approach to defining chronic pain. Pain (2005) 1.33
Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev (2007) 1.31
Demographic factors, denture status and oral health-related quality of life. Community Dent Oral Epidemiol (2004) 1.31
Cross-sectional and longitudinal associations of neighborhood cohesion and stressors with depressive symptoms in the multiethnic study of atherosclerosis. Ann Epidemiol (2009) 1.29
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat (2010) 1.29
Adverse events after screening and follow-up colonoscopy. Cancer Causes Control (2011) 1.27
Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm (2008) 1.23
German short forms of the Oral Health Impact Profile. Community Dent Oral Epidemiol (2006) 1.19
Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Arch Otolaryngol Head Neck Surg (2009) 1.19
Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity. Prostate (2010) 1.19
Increase in cancer detection and recall rates with independent double interpretation of screening mammography. AJR Am J Roentgenol (2003) 1.19
Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study. Breast J (2012) 1.18